Immunogenicity of 23-valent pneumococcal polysaccharide vaccine in HIV-infected pregnant women and kinetics of passively acquired antibodies in young infants

Vaccine

Volumn 27, Issue 29, 2009, Pages 3856-3861

  Almeida, Volia De Carvalho ^a   Mussi Pinhata, Marisa Márcia ^b   Souza, Cleonice Barbosa Sandoval De ^b   Kubo, Christina Arslanian ^b   Martinez, Edson Zangiacomi ^b   Carneiro Sampaio, Magda Maria ^b   Duarte, Geraldo ^b  

^a FEDERAL UNIVERSITY OF SÃO CARLOS   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

HIV infected pregnant woman; Passively acquired pneumococcal antibodies; Pneumococcal polysaccharide vaccine

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; MATERNAL ANTIBODY; PNEUMOCOCCUS POLYSACCHARIDE; PNEUMOCOCCUS VACCINE; POLYSACCHARIDE VACCINE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; ZIDOVUDINE;

ADULT; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG SAFETY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOGENICITY; INFANT; PASSIVE IMMUNIZATION; PLACENTAL TRANSFER; PNEUMOCOCCAL INFECTION; PREGNANT WOMAN; PRIORITY JOURNAL; SEROTYPE;

ADOLESCENT; ADULT; ANTIBODIES, BACTERIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HIV INFECTIONS; HUMANS; IMMUNITY, MATERNALLY-ACQUIRED; IMMUNOGLOBULIN G; INFANT; INFANT, NEWBORN; MIDDLE AGED; PNEUMOCOCCAL VACCINES; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANT WOMEN; YOUNG ADULT;

EID: 67349170471     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.04.018     Document Type: Article

References (50)

1. The WHO Young Infants Study Group. Clinical prediction of serious bacterial infections in young infants in developing countries. Pediatr Infect Dis J 18 10 Suppl. (1999) S23-31
2. Farley J.J., King Jr. J.C., Nair P., Hines S.E., Tressler R.L., and Vink P.E. Invasive pneumococcal disease among infected and uninfected children of mothers with human immunodeficiency virus infection. J Pediatr 124 6 (1994) 853-858
3. Oddy W.H. The impact of breastmilk on infant and child health. Breastfeed Rev 10 3 (2002) 5-18
4. Rodriguez-Barradas M.C., Tharapel R.A., Groover J.E., Giron K.P., Lacke C.E., Houston E.D., et al. Colonization by Streptococcus pneumoniae among human immunodeficiency virus-infected adults: prevalence of antibiotic resistance, impact of immunization, and characterization by polymerase chain reaction with BOX primers of isolates from persistent S. pneumoniae carriers. J Infect Dis 175 3 (1997) 590-597
5. Kirkwood B.R., Gove S., Rogers S., Lob-Levyt J., Arthur P., and Campbell H. Potential interventions for the prevention of childhood pneumonia in developing countries: a systematic review. Bull WHO 73 6 (1995) 793-798
6. Mussi-Pinhata M.M., Cervi M.C., and Isaac M.L. Predicting perinatal HIV infection in young Brazilian infants: How accurate are signs, symptoms and immunological abnormalities?. Int J STD AIDS 12 3 (2001) 197-203
7. Mussi-Pinhata M.M., Freimanis L., Yamamoto A.Y., Korelitz J., Pinto J.A., Cruz M.L., et al. Infectious disease morbidity among young HIV-1-exposed but uninfected infants in Latin American and Caribbean countries: the National Institute of Child Health and Human Development International Site Development Initiative Perinatal Study. Pediatrics 119 3 (2007) e694-704
8. Overturf GD. American Academy of Pediatrics. Committee on Infectious Diseases. Technical report: prevention of pneumococcal infections, including the use of pneumococcal conjugate and polysaccharide vaccines and antibiotic prophylaxis. Pediatrics 2000;106 (2 Pt 1): 367-376.
9. Black S., Shinefield H., Fireman B., Lewis E., Ray P., Hansen J.R., et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J 19 3 (2000) 187-195
10. Rodriguez-Barradas M.C., Goulet J., Brown S., Goetz M.B., Rimland D., Simberkoff M.S., et al. Impact of pneumococcal vaccination on the incidence of pneumonia by HIV infection status among patients enrolled in the Veterans Aging Cohort 5-Site Study. Clin Infect Dis 46 7 (2008) 1093-1100
11. Penaranda M., Falco V., Payeras A., Jordano Q., Curran A., Pareja A., et al. Effectiveness of polysaccharide pneumococcal vaccine in HIV-infected patients: a case-control study. Clin Infect Dis 45 7 (2007) e82-e87
12. Kroon F.P., van Dissel J.T., de Jong J.C., and van Furth R. Antibody response to influenza, tetanus and pneumococcal vaccines in HIV-seropositive individuals in relation to the number of CD4+ lymphocytes. AIDS 8 4 (1994) 469-476
13. Shahid N.S., Steinhoff M.C., Hoque S.S., Begum T., Thompson C., and Siber G.R. Serum, breast milk, and infant antibody after maternal immunisation with pneumococcal vaccine. Lancet 346 8985 (1995) 1252-1257
14. O'Dempsey T.J., McArdle T., Ceesay S.J., Banya W.A., Demba E., Secka O., et al. Immunization with a pneumococcal capsular polysaccharide vaccine during pregnancy. Vaccine 14 10 (1996) 963-970
15. Munoz F.M., Englund J.A., Cheesman C.C., Maccato M.L., Pinell P.M., Nahm M.H., et al. Maternal immunization with pneumococcal polysaccharide vaccine in the third trimester of gestation. Vaccine 20 5-6 (2001) 826-837
16. Lehmann D., Pomat W.S., Combs B., Dyke T., and Alpers M.P. Maternal immunization with pneumococcal polysaccharide vaccine in the highlands of Papua New Guinea. Vaccine 20 13-14 (2002) 1837-1845
17. Lehmann D., Pomat W.S., Riley I.D., and Alpers M.P. Studies of maternal immunisation with pneumococcal polysaccharide vaccine in Papua New Guinea. Vaccine 21 24 (2003) 3446-3450
18. Quiambao B.P., Nohynek H., Kayhty H., Ollgren J., Gozum L., Gepanayao C.P., et al. Maternal immunization with pneumococcal polysaccharide vaccine in the Philippines. Vaccine 21 24 (2003) 3451-3454
19. Quiambao B.P., Nohynek H.M., Kayhty H., Ollgren J.P., Gozum L.S., Gepanayao C.P., et al. Immunogenicity and reactogenicity of 23-valent pneumococcal polysaccharide vaccine among pregnant Filipino women and placental transfer of antibodies. Vaccine 25 22 (2007) 4470-4477
20. de Moraes-Pinto M.I., Almeida A.C., Kenj G., Filgueiras T.E., Tobias W., Santos A.M., et al. Placental transfer and maternally acquired neonatal IgG immunity in human immunodeficiency virus infection. J Infect Dis 173 5 (1996) 1077-1084
21. Castro K.G., Ward J.W., Slutsker L., Buehler J.W., Jaffe H.W., Berkelman R.L., and Curran J.W. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 41 RR-17 (1992) 1-19
22. Frisancho A.R. New norms of upper limb fat and muscle areas for assessment of nutritional status. Am J Clin Nutr 34 11 (1981) 2540-2545
23. Quataert S., Martin D., Anderson P., Giebink G.S., Henrichsen J., Leinonen M., et al. A multi-laboratory evaluation of an enzyme-linked immunoassay quantitating human antibodies to Streptococcus pneumoniae polysaccharides. Immunol Invest 30 3 (2001) 191-207
24. Inostroza J., Villanueva S., Mason K., Leiva L.E., and Sorensen R.U. Effects of absorption with pneumococcal type 22F polysaccharide on maternal, cord blood, and infant immunoglobulin G antipneumococcal polysaccharide antibodies. Clin Diagn Lab Immunol 12 6 (2005) 722-726
25. Brown H.P.R. Applied mixed models in medicine. 2nd ed. (2006), John Wiley & Sons, New York
26. Littell R.C., Milliken G.A., Stroup W.W., Wolfinger R.D., and Schabenberber O. SAS for mixed models. 2nd ed. (2006), SAS Institute Inc., Cary
27. Siber G.R., Chang I., Baker S., Fernsten P., O'Brien K.L., Santosham M., et al. Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies. Vaccine 25 19 (2007) 3816-3826
28. Mantese O.C., Paula A., Moraes A.B., Moreira T.A., Guerra M.L., and Brandileone M.C. Prevalence of serotypes and antimicrobial resistance of invasive strains of Streptococcus pneumoniae. J Pediatr (Rio J) 79 6 (2003) 537-542
29. Amendola A., Tanzi E., Zappa A., Colzani D., Boschini A., Musher D.M., et al. Safety and immunogenicity of 23-valent pneumococcal polysaccharide vaccine in HIV-1 infected former drug users. Vaccine 20 31-32 (2002) 3720-3724
30. Goetz M.B., Feikin D.R., Lennox J.L., O'Brien W.A., Elie C.M., Butler J.C., et al. Viral load response to a pneumococcal conjugate vaccine, polysaccharide vaccine or placebo among HIV-infected patients. AIDS 16 10 (2002) 1421-1423
31. Brichacek B., Swindells S., Janoff E.N., Pirruccello S., and Stevenson M. Increased plasma human immunodeficiency virus type 1 burden following antigenic challenge with pneumococcal vaccine. J Infect Dis 174 6 (1996) 1191-1199
32. Keller M., Deveikis A., Cutillar-Garcia M., Gagajena A., Elkins K., Plaeger S., et al. Pneumococcal and influenza immunization and human immunodeficiency virus load in children. Pediatr Infect Dis J 19 7 (2000) 613-618
33. Matida L.H., da Silva M.H., Tayra A., Succi R.C., Gianna M.C., Goncalves A., et al. Prevention of mother-to-child transmission of HIV in Sao Paulo State, Brazil: an update. AIDS 19 Suppl. 4 (2005) S37-S41
34. Joao E.C., Cruz M.L., Menezes J.A., Matos H.J., Calvet G.A., d'Ippolito M.M., et al. Vertical transmission of HIV in Rio de Janeiro, Brazil. AIDS 17 12 (2003) 1853-1855
35. Mofenson L.M. Advances in the prevention of vertical transmission of human immunodeficiency virus. Semin Pediatr Infect Dis 14 4 (2003) 295-308
36. Go E.S., and Ballas Z.K. Anti-pneumococcal antibody response in normal subjects: a meta-analysis. J Allergy Clin Immunol 98 1 (1996) 205-215
37. Simonsen V., Brandao A.P., Brandileone M.C., Yara T.I., Di Fabio J.L., Lopes M.H., et al. Immunogenicity of a 23-valent pneumococcal polysaccharide vaccine in Brazilian elderly. Braz J Med Biol Res 38 2 (2005) 251-260
38. Janoff E.N., Fasching C., Ojoo J.C., O'Brien J., and Gilks C.F. Responsiveness of human immunodeficiency virus type 1-infected Kenyan women with or without prior pneumococcal disease to pneumococcal vaccine. J Infect Dis 175 4 (1997) 975-978
39. French N., Nakiyingi J., Carpenter L.M., Lugada E., Watera C., Moi K., et al. 23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial. Lancet 355 9221 (2000) 2106-2111
40. Ahmed F., Steinhoff M.C., Rodriguez-Barradas M.C., Hamilton R.G., Musher D.M., and Nelson K.E. Effect of human immunodeficiency virus type 1 infection on the antibody response to a glycoprotein conjugate pneumococcal vaccine: results from a randomized trial. J Infect Dis 173 1 (1996) 83-90
41. Rodriguez-Barradas M.C., Alexandraki I., Nazir T., Foltzer M., Musher D.M., Brown S., et al. Response of human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy to vaccination with 23-valent pneumococcal polysaccharide vaccine. Clin Infect Dis 37 3 (2003) 438-447
42. Feikin D.R., Elie C.M., Goetz M.B., Lennox J.L., Carlone G.M., Romero-Steiner S., et al. Specificity of the antibody response to the pneumococcal polysaccharide and conjugate vaccines in human immunodeficiency virus-infected adults. Clin Diagn Lab Immunol 11 1 (2004) 137-141
43. Concepcion N.F., and Frasch C.E. Pneumococcal type 22f polysaccharide absorption improves the specificity of a pneumococcal-polysaccharide enzyme-linked immunosorbent assay. Clin Diagn Lab Immunol 8 2 (2001) 266-272
44. French N., Moore M., Haikala R., Kayhty H., and Gilks C.F. A case-control study to investigate serological correlates of clinical failure of 23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults. J Infect Dis 190 4 (2004) 707-712
45. Lesprit P., Pedrono G., Molina J.M., Goujard C., Girard P.M., Sarrazin N., et al. Immunological efficacy of a prime-boost pneumococcal vaccination in HIV-infected adults. AIDS 21 18 (2007) 2425-2434
46. Baril L., Briles D.E., Crozier P., King J.D., Hollingshead S.K., Murphy T.F., et al. Natural materno-fetal transfer of antibodies to PspA and to PsaA. Clin Exp Immunol 135 3 (2004) 474-477
47. Yoon J.K., Lee H.H., Choi B.M., Kim K.B., Park H.Y., Lim J.Y., et al. Transplacental transfer and age-related levels of serum IgG antibodies to the capsular polysaccharides of Streptococcus pneumoniae types 14 and 19 in Korea. J Kor Med Sci 16 1 (2001) 9-14
48. de Moraes-Pinto M.I., Farhat C.K., Fraser W.D., Hart C.A., and Johnson P.M. Human serum beta2-microglobulin levels: correlation with total serum IgG and placental IgG transfer in HIV-infected and non-HIV infected individuals. J Reprod Immunol 42 2 (1999) 167-174
49. Farquhar C., Nduati R., Haigwood N., Sutton W., Mbori-Ngacha D., Richardson B., et al. High maternal HIV-1 viral load during pregnancy is associated with reduced placental transfer of measles IgG antibody. J Acquir Immune Defic Syndr 40 4 (2005) 494-497
50. Vidarsson G., Sigurdardottir S.T., Gudnason T., Kjartansson S., Kristinsson K.G., Ingolfsdottir G., et al. Isotypes and opsonophagocytosis of pneumococcus type 6B antibodies elicited in infants and adults by an experimental pneumococcus type 6B-tetanus toxoid vaccine. Infect Immun 66 6 (1998) 2866-2870